From January 1, 2024 to March 19, 2024, the company has repurchased 74,100 shares, representing 0.21% for ¥242.1 million. With this, the company has completed the repurchase of 1,080,000 shares, representing 2.97% for ¥3,485.1 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,055 JPY | 0.00% | -4.98% | -6.57% |
04-25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
03-21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.57% | 698M | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.